$5650 | Single User
$6650 | Multi User
$8150 | Corporate License
$10000 | Enterprise License

Hemodynamic Monitoring Systems Market by Product (Disposables and Monitors), Type (Invasive, Minimally Invasive, and Non-invasive), End User (Hospitals, Clinics & Ambulatory Care Center, and Home Care Setting), and Region - Global Forecasts to 2023 [Report Updated: 20-08-2018]

Published by MarketsandMarkets: 20 Aug 2018 | 221923 | In Stock

Introduction

“The hemodynamic monitoring systems market is projected to grow at a CAGR of 6.4% during the forecast period.”

The global hemodynamic monitoring systems market is expected to reach USD 1,167.4 million by 2023 from USD 857.8 million in 2018, at a CAGR of 6.4% during the forecast period. Technological advancements in hemodynamic monitoring systems, increasing research into hemodynamic monitoring systems, influx of VC funding, rising prevalence of cardiovascular diseases & diabetes, and government focus on critical care infrastructure & services are expected to drive the growth of the hemodynamic monitoring systems market. However, the risk associated with invasive hemodynamic monitoring, such as sepsis, bleeding, hemorrhage, thrombosis, air embolism, and pulmonary capillary necrosis is expected to restrain the growth of this market to a certain extent.

“By product, the monitors segment is expected to grow at the highest rate during the forecast period.”

Based on product, the global hemodynamic monitoring systems market is segmented into two broad categories—monitors and disposables. The monitors segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the increasing prevalence of CVDs; technological advancements in monitoring systems; increasing funding by government authorities for improving patient-centered care, safety, and efficiency; and the ability of hemodynamic monitors to improve cath lab efficiency.

“By type, the noninvasive systems segment is expected to grow at the highest rate during the forecast period (2018–2023).”

On the basis of type, the hemodynamic monitoring systems market is segmented into invasive, minimally invasive, and noninvasive systems. The noninvasive hemodynamic monitoring systems segment is expected to grow at the highest CAGR during the forecast owing to the benefits it offers such as reduced staffing costs, treatment expenses, and hospital stay. Furthermore, the rising incidence of respiratory disorders; fewer complications of noninvasive hemodynamic monitoring compared to invasive methods, enhanced portability & precision, and ease of use are additional factors driving the growth of this market segment.

“By end user, the clinics and ambulatory care centers segment is expected to grow at the highest rate during the forecast period.”

On the basis of end user, the global hemodynamic monitoring systems market is segmented into hospitals, clinics and ambulatory care centers (ACCs), and home care settings. The clinics and ACCs segment is expected to register the highest CAGR during the forecast period due to the growing number of ambulatory care centers globally, improving reimbursements for ACCs, growing number of patients visiting clinics & ACCs, and increasing number of initiatives by governments.

“The Asia Pacific hemodynamic monitoring systems market is expected to grow at the highest CAGR during the forecast period.”

Asia Pacific is expected to witness the highest growth from 2018 to 2023. This high growth rate is attributed to Japan’s growing healthcare industry; extensive government reimbursement coverage for critical cardiac procedures; improving healthcare infrastructure in India and China; high diabetes prevalence in Vietnam, Singapore, Malaysia, China, and India; and government initiatives in Australia and Singapore.

Break of primary participants was as mentioned below:

• By Company Type – Tier 1–55%, Tier 2–25% and Tier 3–20%

• By Designation – C-level–43%, Director Level–32%, Others–25%

• By Region – Europe–38%, North America–23%, Asia Pacific–29%, RoW–10%

The key players in the global hemodynamic monitoring systems market are Edwards Lifesciences Corporation (US), PULSION Medical Systems SE (Germany), LiDCO Group plc (UK), Cheetah Medical (Israel), Deltex Medical Group Plc. (UK), ICU Medical (US), Osypka Medical GmbH (Germany), CareTaker Medical (US), CNSystems (Austria), NI Medical (Israel), and Uscom (Australia).

Research Coverage:

The report analyzes the hemodynamic monitoring systems market and aims at estimating the market size and future growth potential of this market based on various segments such as product, type, end user, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use one or any combination of the below mentioned five strategies.

This report provides insights into the following pointers:

• Market Penetration: Comprehensive information on the product portfolios of the top players in the hemodynamic monitoring systems market. The report analyzes the market based on product, type, end user, and region

• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the hemodynamic monitoring systems market

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various hemodynamic monitoring systems across regions

• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the market

• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the market

Table of Contents
for Hemodynamic Monitoring Systems Market by Product (Disposables and Monitors), Type (Invasive, Minimally Invasive, and Non-invasive), End User (Hospitals, Clinics & Ambulatory Care Center, and Home Care Setting), and Region - Global Forecasts to 2023 [Report Updated: 20-08-2018]

  • TABLE OF CONTENTS

    1 INTRODUCTION 16

    1.1 OBJECTIVES OF THE STUDY 16

    1.2 MARKET DEFINITION 16

    1.3 MARKET SCOPE 17

    1.3.1 YEARS CONSIDERED FOR THE STUDY 17

    1.3.2 MARKETS COVERED 18

    1.4 CURRENCY 18

    1.5 LIMITATIONS 18

    1.6 STAKEHOLDERS 19

    2 RESEARCH METHODOLOGY 20

    2.1 RESEARCH DATA 20

    2.1.1 SECONDARY DATA 21

    2.1.1.1 Key Data from Secondary Sources 21

    2.1.2 PRIMARY DATA 23

    2.1.2.1 Key Data from Primary Sources 24

    2.1.2.2 Key Industry Insights 25

    2.2 MARKET SIZE ESTIMATION METHODOLOGY 26

    2.3 MARKET DATA VALIDATION AND TRIANGULATION 29

    2.4 ASSUMPTIONS FOR THE STUDY 30

    3 EXECUTIVE SUMMARY 31

    4 PREMIUM INSIGHTS 36

    4.1 HEMODYNAMIC MONITORING SYSTEMS MARKET OVERVIEW 36

    4.2 ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY AND END USER 37

    4.3 GEOGRAPHIC SNAPSHOT: GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET 38

    4.4 GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE (2018 VS. 2023) 39

    5 MARKET OVERVIEW 40

    5.1 INTRODUCTION 40

    5.2 MARKET DYNAMICS 40

    5.3 DRIVERS 41

    5.3.1 TECHNOLOGICAL ADVANCEMENTS IN HEMODYNAMIC MONITORING SYSTEMS 41

    5.3.1.1 Microelectromechanical Systems (MEMS) 41

    5.3.1.2 Hypotension Prediction Index (HPI) software 41

    5.3.2 INCREASING RESEARCH INTO HEMODYNAMIC MONITORING SYSTEMS 42

    5.3.3 INFLUX OF VC FUNDING 42

    5.3.4 RISING PREVALENCE OF CARDIOVASCULAR DISEASES AND DIABETES 43

    5.3.5 RISING GERIATRIC POPULATION AND GROWING NUMBER OF SURGERIES 44

    5.3.6 AWARENESS INITIATIVES BY INDUSTRY PLAYERS 45

    5.3.7 GOVERNMENT FOCUS ON CRITICAL CARE INFRASTRUCTURE AND SERVICES 46

    5.4 RESTRAINTS 47

    5.4.1 RISKS ASSOCIATED WITH INVASIVE HEMODYNAMIC MONITORING 47

    5.5 OPPORTUNITIES 47

    5.5.1 EMERGING MARKETS 47

    5.5.2 GROWING DEMAND FOR PATIENT MONITORING DEVICES IN NON-HOSPITAL SETTINGS 48

    5.6 CHALLENGES 48

    5.6.1 INCREASING PRICING PRESSURE ON MARKET PLAYERS 48

    5.6.2 LIMITED PATIENT AWARENESS RELATED TO DISEASE DIAGNOSIS 49

    5.6.3 DEARTH OF SKILLED PROFESSIONALS 49

    6 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT 50

    6.1 INTRODUCTION 51

    6.2 DISPOSABLES 52

    6.3 MONITORS 55

    7 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE 58

    7.1 INTRODUCTION 59

    7.2 INVASIVE HEMODYNAMIC MONITORING SYSTEMS 60

    7.3 MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS 62

    7.4 NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS 65

    8 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER 68

    8.1 INTRODUCTION 69

    8.2 HOSPITALS 70

    8.3 CLINICS AND AMBULATORY CARE CENTERS 72

    8.4 HOME CARE SETTINGS 75

    9 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION 78

    9.1 INTRODUCTION 79

    9.2 NORTH AMERICA 80

    9.2.1 US 83

    9.2.2 CANADA 85

    9.3 EUROPE 86

    9.3.1 GERMANY 90

    9.3.2 UK 93

    9.3.3 FRANCE 95

    9.3.4 ROE 96

    9.4 ASIA PACIFIC 98

    9.4.1 JAPAN 102

    9.4.2 CHINA 104

    9.4.3 INDIA 106

    9.4.4 ROAPAC 108

    9.5 ROW 109

    10 COMPETITIVE LANDSCAPE 114

    10.1 INTRODUCTION 114

    10.2 HEMODYNAMIC MONITORING SYSTEMS MARKET SHARE ANALYSIS 115

    10.2.1 EDWARDS LIFESCIENCES CORPORATION 115

    10.2.2 PULSION MEDICAL SYSTEMS SE 116

    10.2.3 LIDCO GROUP PLC 117

    10.3 HEMODYNAMIC MONITORING SYSTEMS MARKET SHARE ANALYSIS, BY REGION 118

    10.4 COMPETITIVE SCENARIO 120

    11 COMPANY PROFILES 122

    (Business Overview, Strength of Service Portfolio, Business Strategy Excellence, and Key relationships)*

    11.1 EDWARDS LIFESCIENCES CORPORATION 123

    11.2 PULSION MEDICAL SYSTEMS SE (PART OF THE MAQUET GETINGE GROUP) 125

    11.3 LIDCO GROUP 127

    11.4 DELTEX MEDICAL GROUP PLC 130

    11.5 ICU MEDICAL 133

    11.6 CNSYSTEMS MEDIZINTECHNIK GMBH 135

    11.7 CARETAKER MEDICAL 136

    11.8 OSYPKA MEDICAL GMBH 138

    11.9 CHEETAH MEDICAL 139

    *Details on Business Overview, Strength of Service Portfolio, Business Strategy Excellence, and Key relationships might not be captured in case of unlisted companies.

    12 APPENDIX 141

    12.1 DISCUSSION GUIDE: HEMODYNAMIC MONITORING SYSTEMS MARKET 141

    12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 144

    12.3 AVAILABLE CUSTOMIZATIONS 146

    12.4 RELATED REPORTS 146

    12.5 AUTHOR DETAILS 147

List Of Tables
in Hemodynamic Monitoring Systems Market by Product (Disposables and Monitors), Type (Invasive, Minimally Invasive, and Non-invasive), End User (Hospitals, Clinics & Ambulatory Care Center, and Home Care Setting), and Region - Global Forecasts to 2023 [Report Updated: 20-08-2018]

LIST OF TABLES


TABLE 1 INDICATIVE LIST OF COMPANIES THAT RECEIVED VENTURE CAPITALIST FUNDING FOR THE HEMODYNAMIC MONITORING SYSTEMS SEGMENT 42

TABLE 2 TOP FIVE COUNTRIES WITH THE HIGHEST NUMBER OF DIABETICS

(AGED 20–79 YEARS), 2015 VS. 2040 43

TABLE 3 POPULATION AGED 60 YEARS AND OVER, BY REGION (IN MILLION) 44

TABLE 4 AWARENESS INITIATIVES IN 2017–2018 45

TABLE 5 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT,

2016–2023 (USD MILLION) 51

TABLE 6 TYPES OF DISPOSABLES USED IN HEMODYNAMIC MONITORING 52

TABLE 7 HEMODYNAMIC MONITORING DISPOSABLES MARKET, BY REGION,

2016–2023 (USD MILLION) 53

TABLE 8 NORTH AMERICA: HEMODYNAMIC MONITORING MARKET FOR DISPOSABLES,

BY COUNTRY, 2016–2023 (USD MILLION) 53

TABLE 9 EUROPE: HEMODYNAMIC MONITORING MARKET FOR DISPOSABLES, BY COUNTRY, 2016–2023 (USD MILLION) 54

TABLE 10 ASIA PACIFIC: HEMODYNAMIC MONITORING MARKET FOR DISPOSABLES,

BY COUNTRY, 2016–2023 (USD MILLION) 54

TABLE 11 TYPES OF HEMODYNAMIC MONITORS 55

TABLE 12 HEMODYNAMIC MONITORS MARKET, BY REGION, 2016–2023 (USD MILLION) 55

TABLE 13 NORTH AMERICA: HEMODYNAMIC MONITORS MARKET, BY COUNTRY,

2016–2023 (USD MILLION) 56

TABLE 14 EUROPE: HEMODYNAMIC MONITORS MARKET, BY COUNTRY,

2016–2023 (USD MILLION) 56

TABLE 15 ASIA PACIFIC: HEMODYNAMIC MONITORS MARKET, BY COUNTRY,

2016–2023 (USD MILLION) 57

TABLE 16 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE,

2016–2023 (USD MILLION) 59

TABLE 17 INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION,

2016–2023 (USD MILLION) 60

TABLE 18 NORTH AMERICA: INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET,

BY COUNTRY, 2016–2023 (USD MILLION) 61

TABLE 19 EUROPE: INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 61

TABLE 20 ASIA PACIFIC: INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET,

BY COUNTRY, 2016–2023 (USD MILLION) 62

TABLE 21 MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET,

BY REGION, 2016–2023 (USD MILLION) 63

TABLE 22 NORTH AMERICA: MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 63

TABLE 23 EUROPE: MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET,

BY COUNTRY, 2016–2023 (USD MILLION) 64

TABLE 24 ASIA PACIFIC: MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 64

TABLE 25 NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION,

2016–2023 (USD MILLION) 65

TABLE 26 NORTH AMERICA: NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 66

TABLE 27 EUROPE: NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET,

BY COUNTRY, 2016–2023 (USD MILLION) 66

TABLE 28 ASIA PACIFIC: NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET,

BY COUNTRY, 2016–2023 (USD MILLION) 67

TABLE 29 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER,

2016–2023 (USD MILLION) 69

TABLE 30 HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HOSPITALS, BY REGION, 2016–2023 (USD MILLION) 70

TABLE 31 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HOSPITALS, BY COUNTRY, 2016–2023 (USD MILLION) 71

TABLE 32 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HOSPITALS,

BY COUNTRY, 2016–2023 (USD MILLION) 71

TABLE 33 ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HOSPITALS,

BY COUNTRY, 2016–2023 (USD MILLION) 72

TABLE 34 HEMODYNAMIC MONITORING SYSTEMS MARKET FOR CLINICS AND AMBULATORY CARE CENTERS, BY REGION, 2016–2023 (USD MILLION) 73

TABLE 35 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR CLINICS AND AMBULATORY CARE CENTERS, BY COUNTRY, 2016–2023 (USD MILLION) 73

TABLE 36 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR CLINICS AND AMBULATORY CARE CENTERS, BY COUNTRY, 2016–2023 (USD MILLION) 74

TABLE 37 ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR CLINICS

AND AMBULATORY CARE CENTERS, BY COUNTRY, 2016–2023 (USD MILLION) 74

TABLE 38 HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HOME CARE SETTINGS,

BY REGION, 2016–2023 (USD MILLION) 75

TABLE 39 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2016–2023 (USD MILLION) 76

TABLE 40 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2016–2023 (USD MILLION) 76

TABLE 41 ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2016–2023 (USD MILLION) 77

TABLE 42 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION, 2016–2023 (USD MILLION) 80

TABLE 43 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET,

BY COUNTRY, 2016–2023 (USD MILLION) 82

TABLE 44 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET,

BY PRODUCT, 2016–2023 (USD MILLION) 82

TABLE 45 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET,

BY TYPE, 2016–2023 (USD MILLION) 82

TABLE 46 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET,

BY END USER, 2016–2023 (USD MILLION) 83

TABLE 47 US: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT,

2016–2023 (USD MILLION) 84

TABLE 48 US: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE,

2016–2023 (USD MILLION) 84

TABLE 49 US: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER,

2016–2023 (USD MILLION) 85

TABLE 50 CANADA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT,

2016–2023 (USD MILLION) 85

TABLE 51 CANADA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE,

2016–2023 (USD MILLION) 86

TABLE 52 CANADA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER,

2016–2023 (USD MILLION) 86

TABLE 53 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY,

2016–2023 (USD MILLION) 89

TABLE 54 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT,

2016–2023 (USD MILLION) 89

TABLE 55 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE,

2016–2023 (USD MILLION) 90

TABLE 56 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER,

2016–2023 (USD MILLION) 90

TABLE 57 GERMANY: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT,

2016–2023 (USD MILLION) 91

TABLE 58 GERMANY: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE,

2016–2023 (USD MILLION) 92

TABLE 59 GERMANY: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER,

2016–2023 (USD MILLION) 92

TABLE 60 UK: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT,

2016–2023 (USD MILLION) 94

TABLE 61 UK: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE,

2016–2023 (USD MILLION) 94

TABLE 62 UK: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER,

2016–2023 (USD MILLION) 94

TABLE 63 FRANCE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT,

2016–2023 (USD MILLION) 95

TABLE 64 FRANCE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE,

2016–2023 (USD MILLION) 96

TABLE 65 FRANCE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER,

2016–2023 (USD MILLION) 96

TABLE 66 ROE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT,

2016–2023 (USD MILLION) 97

TABLE 67 ROE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE,

2016–2023 (USD MILLION) 98

TABLE 68 ROE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER,

2016–2023 (USD MILLION) 98

TABLE 69 PROMINENT RESEARCH PROJECTS FOCUSING ON HEMODYNAMIC MONITORING 99

TABLE 70 ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 101

TABLE 71 ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 101

TABLE 72 ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE,

2016–2023 (USD MILLION) 102

TABLE 73 ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016–2023 (USD MILLION) 102

TABLE 74 JAPAN: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT,

2016–2023 (USD MILLION) 103

TABLE 75 JAPAN: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE,

2016–2023 (USD MILLION) 104

TABLE 76 JAPAN: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER,

2016–2023 (USD MILLION) 104

TABLE 77 CHINA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT,

2016–2023 (USD MILLION) 105

TABLE 78 CHINA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE,

2016–2023 (USD MILLION) 105

TABLE 79 CHINA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER,

2016–2023 (USD MILLION) 106

TABLE 80 INDIA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT,

2016–2023 (USD MILLION) 107

TABLE 81 INDIA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE,

2016–2023 (USD MILLION) 107

TABLE 82 INDIA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER,

2016–2023 (USD MILLION) 107

TABLE 83 ROAPAC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT,

2016–2023 (USD MILLION) 108

TABLE 84 ROAPAC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE,

2016–2023 (USD MILLION) 109

TABLE 85 ROAPAC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER,

2016–2023 (USD MILLION) 109

TABLE 86 ROW: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT,

2016–2023 (USD MILLION) 112

TABLE 87 ROW: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE,

2016–2023 (USD MILLION) 112

TABLE 88 ROW: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER,

2016–2023 (USD MILLION) 113

TABLE 89 PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS, 2015-2018 120

TABLE 90 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS 120

TABLE 91 OTHER DEVELOPMENTS 121

List Of Figures, Charts and Diagrams
in Hemodynamic Monitoring Systems Market by Product (Disposables and Monitors), Type (Invasive, Minimally Invasive, and Non-invasive), End User (Hospitals, Clinics & Ambulatory Care Center, and Home Care Setting), and Region - Global Forecasts to 2023 [Report Updated: 20-08-2018]

LIST OF FIGURES


FIGURE 1 HEMODYNAMIC MONITORING SYSTEMS MARKET SEGMENTATION 18

FIGURE 2 HEMODYNAMIC MONITORING SYSTEMS MARKET: RESEARCH METHODOLOGY 20

FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,

AND REGION 23

FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 26

FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 27

FIGURE 6 RESEARCH DESIGN 28

FIGURE 7 DATA TRIANGULATION METHODOLOGY 29

FIGURE 8 MONITORS SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD 32

FIGURE 9 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2018 VS 2023 33

FIGURE 10 HOSPITALS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE HEMODYNAMIC MONITORING SYSTEMS MARKET IN 2018 34

FIGURE 11 ASIA PACIFIC TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD 35

FIGURE 12 TECHNOLOGICAL ADVANCEMENTS IN HEMODYNAMIC MONITORING SYTEMS

IS THE KEY FACTOR DRIVING THE GROWTH OF THE MARKET 36

FIGURE 13 HOSPITALS SEGMENT TO DOMINATE THE HEMODYNAMIC MONITORING SYSTEMS MARKET IN 2018 37

FIGURE 14 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 38

FIGURE 15 INVASIVE SYSTEMS SEGMENT TO COMMAND THE LARGEST MARKET SHARE

BY 2023 39

FIGURE 16 PERCENTAGE CHANGE IN POPULATION AGED 60 YEARS AND OVER, BY REGION (2000–2030) 44

FIGURE 17 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT,

2018 VS. 2023 (USD MILLION) 51

FIGURE 18 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2018 VS. 2023 59

FIGURE 19 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER,

2018 VS. 2023 (USD MILLION) 69

FIGURE 20 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION, 2018 VS. 2023 79

FIGURE 21 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET SNAPSHOT 81

FIGURE 22 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET SNAPSHOT 88

FIGURE 23 ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET SNAPSHOT 100

FIGURE 24 ROW: HEMODYNAMIC MONITORING SYSTEMS MARKET SNAPSHOT 111

FIGURE 25 KEY DEVELOPMENTS IN THE HEMODYNAMIC MONITORING SYSTEMS MARKET BETWEEN 2015 AND 2018 114

FIGURE 26 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017 115

FIGURE 27 NORTH AMERICA: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017 118

FIGURE 28 EUROPE: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017 118

FIGURE 29 ASIA PACIFIC: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017 119


FIGURE 30 ROW: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017 119

FIGURE 31 GEOGRAPHIC PRESENCE OF KEY PLAYERS 122

FIGURE 32 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2017) 123

FIGURE 33 PULSION MEDICAL SYSTEMS SE: COMPANY SNAPSHOT (2017) 125

FIGURE 34 LIDCO GROUP: COMPANY SNAPSHOT (2017) 127

FIGURE 35 DELTEX MEDICAL GROUP PLC: COMPANY SNAPSHOT (2017) 130

FIGURE 36 ICU MEDICAL: COMPANY SNAPSHOT (2017) 133

Additional Details

Publisher

MarketsandMarkets

Publisher Information

Reference

221923 | MD 3211

Number of Pages

149

Report Format

PDF

MarketsandMarkets Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Hemodynamic Monitoring System Market Research Report Forecast 2017 to 2021
The Global Hemodynamic Monitoring System Market Research Report Forecast 2017-2021 is a valuable sou...
03 May 2017 by S&P Consulting USD $2,800 More Info
Global Hemodynamic Monitoring System Market Research Report Forecast 2017 to 2022
Delivery of the Report will take 2-3 working days once order is placed.The Global Hemodynamic Monit...
02 May 2017 by S&P Consulting USD $2,800 More Info
Global Hemodynamic Monitoring Device Market Research Report Forecast 2017 to 2021
The Global Hemodynamic Monitoring Device Market Research Report Forecast 2017-2021 is a valuable sou...
26 Apr 2017 by S&P Consulting USD $2,800 More Info
Global Hemodynamic Monitoring Market By Type, By End User and by Region - Industry Analysis, Size, Share, Growth Trends and Forecasts (2017 - 2022)
The global market for hemodynamic monitoring accounted for USD 931.0 million in 2016 and is expected...
01 Feb 2017 by Market Data Forecast USD $4,255 More Info
Diagnostic Catheter Market by Type (Angiography, OCT, Ultrasound, Electrophysiology, Pressure and Hemodynamic Monitoring), Application Area (Cardiology, Urology, Neurology, Gastroenterology), End User (Hospitals, Imaging Centers) - Global Forecast to 2021
The global diagnostic catheters market is projected to reach USD 4.30 billion by 2021 from USD 3.02 ...
06 Jan 2017 by MarketsandMarkets USD $5,650 More Info
Interventional Cardiology & Peripheral Vascular Devices Market by Type (Angioplasty Balloon, Stent, Catheters, EVAR Stent Grafts, Abdominal Aortic Aneurysm, IVC Filter, Plaque Modification, Hemodynamic Flow Alteration, Accessories, Guidewire) - Forecasts to 2021
The interventional cardiology and peripheral vascular devices market is expected to reach USD 31.47 ...
16 Dec 2016 by MarketsandMarkets USD $5,650 More Info
Interventional Cardiology & Peripheral Vascular Devices Market by Type (Angioplasty Balloon, Stent, Catheters, EVAR Stent Grafts, Abdominal Aortic Aneurysm, IVC Filter, Plaque Modification, Hemodynamic Flow Alteration, Accessories, Guidewire) - Forecasts to 2021
The interventional cardiology and peripheral vascular devices market is expected to reach USD 31.47 ...
16 Dec 2016 by MarketsandMarkets USD $5,650 More Info
World Interventional Cardiology & Peripheral Vascular Devices Market by Product (Angioplasty Balloons, Angioplasty Stents, Angioplasty Catheters, Endovascular Aneurysm Repair Stent Grafts, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Accessories) - Global Opportunity Analysis and Industry Forecast, 2014-2022
Interventional cardiology is a branch of cardiology that focuses on catheter-based technologies for ...
01 Oct 2016 by Allied Market Research USD $4,740 More Info
World Interventional Cardiology & Peripheral Vascular Devices Market by Product (Angioplasty Balloons, Angioplasty Stents, Angioplasty Catheters, Endovascular Aneurysm Repair Stent Grafts, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Accessories) - Global Opportunity Analysis and Industry Forecast, 2014-2022
Interventional cardiology is a branch of cardiology that focuses on catheter-based technologies for ...
01 Oct 2016 by Allied Market Research USD $5,370 More Info
Hemodynamic Monitoring System Market by Product (Systems and Disposables), by Type (Invasive, Minimally Invasive, Non-Invasive), by End-User (Hospitals, Cath Labs, Home and Ambulatory Sites) - Analysis & Global Forecast to 2019
Over the years, the hemodynamic monitoring systems market has witnessed various technological advanc...
05 Mar 2015 by MarketsandMarkets USD $5,650 More Info

This report is published by MarketsandMarkets

Download Free Report Summary PDF

Hemodynamic Monitoring Systems Market by Product (Disposables and Monitors), Type (Invasive, Minimally Invasive, and Non-invasive), End User (Hospitals, Clinics & Ambulatory Care Center, and Home Care Setting), and Region - Global Forecasts to 2023 [Report Updated: 20-08-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data